Kuros Biosciences AG banner

Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 22.94 CHF -1.29% Market Closed
Market Cap: CHf898.8m

Intrinsic Value

The intrinsic value for Kuros Biosciences AG (KURN) under the Base Case is 28.31 CHF. Compared with the current market price of 22.94 CHF, the stock appears Undervalued by 19%.

Based on two methods:

DCF suggests undervaluation, while multiples suggest overvaluation.

KURN Intrinsic Value
28.31 CHF
Undervaluation 19%
Intrinsic Value
Price CHf22.94
Base Case Scenario
Get notified when the price drop
Track Buy Zone
20% below Intrinsic Value CHf22.65
Get notified when the price drops into your buy zone
Intrinsic Value CHf28.31
Current Price CHf22.94
Margin of Safety 20% CHf22.65
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about KURN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is KURN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Kuros Biosciences AG.

Explain Valuation
Alternatives to KURN

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Kuros Biosciences AG

Wall St
Price Targets

Dividends

Kuros Biosciences AG
does not pay dividends
Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one KURN stock?

The intrinsic value for Kuros Biosciences AG (KURN) under the Base Case is 28.31 CHF.

Is KURN stock undervalued or overvalued?

Compared with the current market price of 22.94 CHF, the stock appears Undervalued by 19%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett